Answers are grounded in this paper and cite their sources.
The serum bile acid profile, the hepatic gene expression pattern and the gut microbiome composition consistently support an elevated bile acid production in NAFLD. The increased proportion of FXR antagonistic bile acid explains, at least in part, the suppression of hepatic FXR-mediated and FGFR4-mediated signalling. Our study suggests that future NAFLD intervention may target the components of FXR signalling, including the bile acid converting gut microbiome.
No takes yet. Share an insight, caveat, or question.
Jiao et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: